Conference News

May 14, 2026

Tirofiban After Tenecteplase in Stroke

Adjunctive tirofiban was linked to higher rates of positive 90-day outcomes in acute ischemic stroke.

Conexiant

May 14, 2026

Tenecteplase Prior to EVT Did Not Improve Stroke Outcomes

Phase 3 trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.

Conexiant

May 13, 2026

AI Discharge Summaries Show Low Harm Risk

Most reviewed summaries were rated as posing no harm risk, although omissions remained common.

Conexiant

May 13, 2026

PCOS Renamed PMOS After Global Consensus

International initiative reframes a common endocrine disorder around its metabolic and ovarian features rather than ovarian cysts

Conexiant

May 12, 2026

Digitalis Reduces HF Events but Not Mortality

Meta-analysis of randomized trials found fewer worsening heart failure events among patients with reduced or mildly reduced ejection fraction

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

May 06, 2026

Rapid AST Speeds Care, Not Outcomes

Faster antibiotic optimization may still support use of rapid testing, particularly when paired with stewardship.

Conexiant

May 06, 2026

Dalbavancin Exposure Linked to Higher Success in Bacteremia

Higher day 22 concentrations were associated with improved outcomes, though findings remain exploratory

Conexiant

April 29, 2026

FDA Monthly Preview: Key May Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Conexiant

April 20, 2026

Amoxicillin-Clavulanate vs Amoxicillin for Sinusitis

Amoxicillin-clavulanate was not linked to lower treatment failure but was associated with a slightly higher risk of secondary infections compared with amoxicillin in adults with uncomplicated acute sinusitis.

Conexiant

April 17, 2026

Radiology Groups Push Back on New Cancer Screening Guidelines

Radiology groups say the ACP's new screening recommendations conflict with nearly every major cancer organization and could cost thousands of lives annually.

Conexiant

Side Effects: Nobody Trained for This

Conference News

Tirofiban After Tenecteplase in Stroke

Tenecteplase Prior to EVT Did Not Improve Stroke Outcomes

AI Discharge Summaries Show Low Harm Risk

PCOS Renamed PMOS After Global Consensus

Digitalis Reduces HF Events but Not Mortality

Daily News

Rapid AST Speeds Care, Not Outcomes

Dalbavancin Exposure Linked to Higher Success in Bacteremia

FDA Monthly Preview: Key May Decisions to Watch

Amoxicillin-Clavulanate vs Amoxicillin for Sinusitis

Radiology Groups Push Back on New Cancer Screening Guidelines

Recommendations

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Trending Now

Side Effects: Nobody Trained for This

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dental Technology

Inside Dentistry

The ASCO Post

JADPRO

JNCCN

JNCCN 360

Corneal Physician

Glaucoma Physician

New Retinal Physician

Ophthalmology Management

Ophthalmic Professional

Presbyopia Physician

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

Presbyopia Physician

The New Optometrist

The Pathologist

Conference News

Daily News

Recommendations